The landscape of generative artificial intelligence has grown increasingly fragmented over recent years, forcing modern professionals, developers, and enterprises to…
Read More
Bioengineered Bone Marrow-on-a-Chip Platform Revolutionizes Human Hematopoiesis Research and Drug Toxicity Screening
The human bone marrow is a complex, sequestered organ that serves as the primary engine for the body’s circulatory and…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
More than a decade ago, the American Society of Clinical Oncology (ASCO) initiated CancerLinQ, a pioneering platform designed with the…
Read More
Moderna Bets on mRNA’s Second Act with Cancer, Autoimmune Programs, and AI Research Platform
At its recent annual Science Day, Moderna signaled a profound strategic shift, moving beyond its foundational infectious disease vaccine and…
Read More
Bioengineered Bone Marrow-on-a-Chip Platform Replicates Human Immune Response and Advances Drug Development Capabilities
The human skeletal system serves as more than just a structural framework; deep within the cavities of our bones lies…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
Over a decade ago, the American Society of Clinical Oncology (ASCO) initiated a groundbreaking endeavor with the launch of CancerLinQ,…
Read More
A Groundbreaking Viral ORFeome Platform Revolutionizes Human Disease Research and Pandemic Preparedness
A novel viral ORFeome proteomics platform has been unveiled, marking a monumental leap in virology by enabling the expansive analysis…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
At its recent annual Science Day, biotechnology giant Moderna signaled a profound strategic expansion beyond its highly successful infectious disease…
Read More
How ConcertAI turned CancerLinQ into a point-of-care oncology intelligence platform
In a significant advancement for precision oncology, ConcertAI, a leading AI and real-world data company focused on cancer care, has…
Read More
Moderna bets on mRNA’s second act with cancer, autoimmune programs and AI research platform
Moderna, the biotechnology firm that gained global prominence for its mRNA-based COVID-19 vaccine, is embarking on a significant strategic pivot,…
Read More
